ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 615538 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 615538; 2) Community: the network communities that were significantly associated with the response to NSC 615538; 3) Molecule: the relationships between components within communities and NSC 615538; 4) MDR: the compounds that were significantly associated with the NSC 615538.

NSC Compound Enrichment Correlation
NSC 749600 Null 0.0329129886465387 0.32238255
NSC 750050 Null 0.0329129886465387 0.22557624
NSC 752278 2,7-Bis-[2-(2,3,4-trimethoxy-benzylamino)-ethyl]-benzo[lmn][3,8]phenanthroline-1,3,6,8-tetraone di-p-toluensulfonate salt 0.0329129886465387 0.17875296
NSC 752346 Null 0.0329129886465387 0.28885192
NSC 762901 trans-4-{4-[3-(4-chloro-3-trifluoromethyl-phenyl)-ureido]-cyclohexyloxy}-pyridine-2-carboxylic acid methylamide 0.0329129886465387 0.34258597
NSC 93819 Depakine 0.0329129886465387 0.086244208
NSC 163949 3,6-Diamino-10-methylacridinium chloride hydrochloride 0.0329129886465389 0.085955592
NSC 367480 Null 0.0329129886465389 -0.19516353
NSC 107043 Null 0.0375780807984386 0.25733889
NSC 132791 Butyric acid, 2-hydroxy-2-methyl-, 4-ester with 1,3a.beta.,4,7,7a.alpha.,11,11a,11b.alpha.-octahydro-1.alpha.,2.alpha.,4.beta.,11.beta.-tetrahydroxy-3.alpha.,8,11a.beta.-trimethyl-2H-1,11c.beta.-(epo 0.0375780807984386 0.60358145
Total:77  Current:58    [First] [Prev] [Next] [Last]